We are driven by the three core values of quality, affordability and accessibility.
Our efforts have been recognized by various publications.
Newspaper Advertisement of Annual General Meeting and E-voting Instructions
Intimation of Notice of 32nd Annual General Meeting and Annual Report for the F.Y. 2022-23
Intimation of Business Responsibility & Sustainability Report for F.Y. 2022-23
Newspaper Advertisement of Annual General Meeting to be held through Video Conference/ Other Audio-Visual Means
Intimation of closure of trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of Board Meeting dated August 02, 2023
Investor Presentation on the Financial Results for the Quarter ended June 30, 2023
Press Release – Financial Results for the Quarter ended June 30, 2023
Intimation of Resignation of Mr. Leonard Lee Kim
Intimation under Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015
Intimation under Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015- Update
Outcome of the Board Meeting dated 30th May 2023
Authorised Key Managerial Personnel to determine materiality of an event or information and its disclosure
Intimation under Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Newspaper Publication of Consolidated Audited Financial Results for the quarter and financial year ended 31st March 2023
Annual Secretarial Compliance Report for the year ended 31st March 2023
Audited Standalone and Consolidated Financial Results for the year ended 31st March 2023
Disclosure of Related Party Transactions for the half year ended 31st March 2023
Intimation of Performance and Business Update Call on Q4FY23 & FY23 with Senior Management of Mankind Pharma Limited
Investor Presentation
Press Release- Financial Results for the quarter and financial year ended on 31st March 2023
Intimation of Investor Conference Call for Q1FY24 with Senior Management of Mankind Pharma Limited
Outcome of Board Meeting dated August 24, 2023
Intimation about change in Corporate Identification Number
Intimation of Schedule of Analyst/ Institutional Investor Meeting
Proceedings of 32nd Annual General Meeting of the Company
Intimation of Commencement of Commercial Operations at Udaipur Plant
